What if a biotech company could flip its financial narrative from loss to profit in just a year? Twist Bioscience Corporation (NASDAQ:TWST) has done just that, reporting a surprising third-quarter income that defied analysts’ expectations
On Monday, Twist Bioscience reported a third-quarter income of 33 cents per share, a turnaround from a loss of $1.47 a year ago. The analyst consensus was a loss of 55 cents.
